Echocardiographic Evaluation of
Right Ventricular Function in
Patients with Chronic Pre-Capillary
Pulmonary Hypertension

Stefano Ghio, Laura Scelsi, Michele Pasotti,
Giulia Magrini, Alessandra Serio, Lorenzo Monti

Dipartimento di Cardiologia, IRCCS Policlinico S. Matteo,
Pavia, Italy.


In chronic pre-capillary pulmonary hypertension the right ventricle undergoes extensive remodeling (an increase in volume, a change in shape and an increase in wall thickness) that allows it to maintain an adequate right ventricular (RV) output at rest despite the high afterload. The anatomic characteristics of the pressure overloaded right ventricle have been described using various imaging techniques, including echocardiography and nuclear magnetic resonance [1-4]. However, despite a widespread agreement on the importance of right ventricular function in patients with chronic pulmonary hypertension (both to guide therapy and for risk stratification) the non-invasive assessment of right ventricular morphology and function by means of echocardiography has traditionally been hampered by the complex geometry of this cardiac chamber, so that its evaluation has often been qualitative [5-8].

Recently, two echocardiographic parameters describing right heart performance (the tricuspid annular plane systolic excursion and the Doppler derived flow velocity pattern into the superior vena cava) turned out to be clinically and prognostically useful in advanced heart failure [9-10]. The hemodynamic correlates of these parameters have not been reported in patients with chronic pulmonary hypertension. In addition, there is still a substantial lack of knowledge concerning the relationship between RV morphology and function; in particular, it is still debated whether or not right ventricular hypertrophy might be associated with a better hemodynamic profile and a better prognosis in such patients by permitting a better coupling of the right ventricle with the increased RV wall stress [11-12].

Accordingly, the aim of this prospective study was to define the capability of echocardiography to assess the right heart performance in such patients.

Methods
Patients. Between January 1996 and May 2001, 142 patients were consecutively admitted at our institution because of symptomatic pulmonary hypertension and were diagnosed as having chronic postembolic pulmonary hypertension (n=111: 54 males and 57 females, mean age 51±14 years, 57% in NYHA class III or IV) or primary pulmonary hypertension (n=31: 13 males and 18 females, mean age 45±15 years, 61% in NYHA class III or IV). Patients with a history of drug abuse, HIV infection, chronic obstructive pulmonary disease, interstitial lung disease or collagen vascular disease were not included in this series. Chronic thromboembolic pulmonary hypertension was positively diagnosed when typical pulmonary angiographic findings were present at pulmonary angiography [13, 14]. The diagnosis of primary pulmonary hypertension was done after having ruled out the most representative etiologies of pulmonary hypertension [15]. All patients underwent right heart catheterization and ultrasound examination during the hospitalization period.

Echocardiographic and Doppler Study. A complete M-mode, 2-D and Doppler study was performed using standard parasternal, apical and subcostal approaches, as previously described [16]. The right ventricular end-diastolic diameter and the thickness of the right ventricle free wall were determined in the parasternal view [17]. End-diastolic and end-systolic right ventricular areas were measured in the apical view and the fractional area change was calculated as (end-diastolic area minus end-systolic area) divided by end-diastolic area, x 100. The systolic displacement of the lateral portion of the tricuspid annular plane was measured on the M-mode tracing under the 2D-echo guidance. Tricuspid regurgitation was graded using the jet area method. The diameter of the inferior vena cava was measured from the subcostal approach and its inspiratory collapsibility evaluated [18]. Peak systolic pulmonary artery pressure was calculated by adding a right atrial pressure estimate to the systolic transtricuspid pressure gradient; the right atrial pressure was estimated = 5 mmHg when the inferior vena cava diameter was <20 mm and the collapsibility ³50%; the estimate was 10 mmHg when the inferior vena cava diameter was <20 mm and the collapsibility <50%; the estimate was 20 mmHg when the inferior vena cava diameter was ³ 20 mm and the collapsibility <50%. The pulsed Doppler pulmonary flow velocity curve was analyzed to measure the acceleration time and to detect the presence of a mid-systolic notch [19]. The superior vena cava flow velocity curve was recorded from the right supraclavear approach by placing the sample volume in the middle of the stream visualized by color-Doppler format. Peak velocities of the systolic and of the diastolic centripetal waves in superior vena cava and hepatic veins were measured and their ratio calculated. The venous flow velocity pattern was considered normal when the systolic/diastolic ratio was ³ 1 and 2; the flow pattern was categorized as "predominant systolic wave" when the ratio was > 2, and as "predominant diastolic wave" when the ratio was < 1 [20]. "Reverse systolic flow" was identified when a retrograde holosystolic wave was present. Left ventricular end-diastolic and end-systolic volumes and left ventricular ejection fraction were calculated using the area-length method. The eccentricity index of the left ventricle was calculated in diastole and in systole. Echocardiographic data were averaged over 3 beats. All Doppler measurements were evaluated in 5 consecutive beats obtained during quiet respiration.

Right heart catheterization. The procedure has been previously described in detail [21]. Briefly, a modified Swan Ganz thermodilution catheter with a rapid response thermistor (93A-431H- 7F, American Edwards Laboratories, Irvine CA) was inserted transcutaneously via the right internal jugular vein. The thermistor was connected to a dedicated computer (REF-1 Ejection Fraction/Cardiac Output Computer, American Edwards Laboratories) to display on-line the cardiac output and the right ventricular ejection fraction. The following hemodynamic parameters were measured or calculated: systemic blood pressure (arm-cuff sphygmomanometer), right atrial pressure, pulmonary artery (systolic, diastolic and mean) pressure and pulmonary wedge pressure, RV ejection fraction, cardiac output, cardiac index, systemic vascular resistance, pulmonary vascular resistance. All of the thermodilution measurements were obtained in triplicate. On average, the time interval between the ultrasound examination and the right heart catheterization was one day.

Statistical analysis. Data are shown as mean ± SD for continuous variables and absolute or relative frequencies for categorical variables. Group means were compared using the two-tailed t test; group frequencies were compared using the chi-square test.

Linear regression analysis was performed to evaluate the correlations between echocardiographic and hemodynamic parameters.

Cumulative survival was calculated on the basis of Kaplan-Meier estimates; the relative risk of dying and its 95% confidence interval (95%CI) were computed using a Cox model. Cardiac death was the only end-point of survival analysis; lung transplantation and pulmonary thromboendoarterectomy were considered as censored observations and the patients were withdrawn from the analysis at the time of intervention. A p value < 0.05 was retained for statistical significance.

Results
Non-invasive estimation of right atrial pressure. Echocardiographic data for estimation of right atrial pressure could be recorded in 112 patients. The flow velocity pattern into the superior vena cava yielded slightly better results than the size and collapsibility of the inferior vena cava.

Echocardiographic prediction of right atrial pressure
Doppler equation
Right atrial pressure (mmHg) = 3.48 + 1.57a + 8.25b
Where a = 1 if the flow pattern is "predominant systolic wave" or 0 in other cases and b = 1 if the flow pattern is "predominant diastolic wave" or "reverse systolic flow" or = 0 in other cases (adjusted R2 = 0.290).
Echocardiographic prediction of right atrial pressure
Two-dimensional equation

right atrial pressure (mmHg) = 2.86 + 3.05a + 5.80b
where a = 1 if the inferior vena cava diameter is <20 mm and the collapsibility <50% or = 0 in other cases and b = 1 if the inferior vena cava diameter is ³20 mm and the collapsibility <50% or = 0 in other cases (adjusted R2 = 0.177).

Non-invasive estimation of pulmonary arterial pressure. The echocardiographic estimate of peak systolic pulmonary artery pressure was feasible in 103 patients.

Echocardiographic estimate of pulmonary artery pressure
Feasibility: in 103/142 patients Accuracy: underestimation by
0.24 ± 19.9 mmHg (95% limits of agreement according to Bland and Altman: -39.29 to 38.8)

Non-invasive evaluation of right ventricular performance. The geometry and function of the right ventricle turned out to be related to the hemodynamic severity of pulmonary hypertension. Echocardiographic and hemodynamic indices of right ventricular performance were significantly correlated.

Correlations between mean pulmonary artery pressure and echo parameters of right ventricular morphology and function.

Tabla 1

Correlations between thermodilution-derived right ventricular ejection fraction and the echo indices of RV function
Thermodilution-derived RVEF and tricuspid annular plane systolic escursion (r=0.51, p<0.001)
Tthermodilution-derived RVEF and right ventricular fractional area change (r=0.48, p<0.001).

Tabla 2

The clinical significance of right ventricular hypertrophy
The median right ventricular wall thickness in the whole was 7 mm (range 3-14 mm). Patients were accordingly divided into two groups: those with "severe" hypertrophy (RVWT 7mm) and those with "moderate" hypertrophy (RVWT = 7 mm).

Tabla 3

 

Figura

Discussion
The present study underlines the role of transthoracic echocardiography in the evaluation of the right heart performance in patients with chronic pulmonary hypertension.

Doppler assessment of right sided pressures. The interpretation of the comparison between Doppler-derived hemodynamic variables and direct pressure measurements in the present study requires particular caution. In fact, echocardiography and right heart catheterization were not performed simultaneously; furthermore, standard fluid-filled catheters rather than micromanometer-tipped catheters were used for pressure measurements [22]. Nonetheless, the results of the present study confirm that the non-invasive estimation of right sided pressures from Doppler spectral recordings of the tricuspid regurgitant velocities is feasible in a great percentage of patients with pulmonary hypertension. Echocardiographic data are similar to invasive data if we only look at mean values; however, we must be aware that the wide limits of agreement indicate that clinically significant differences might occur in individual patients. As far as the non-invasive estimation of right atrial pressure is concerned, the study indicates that pulsed Doppler velocimetry into the superior vena cava provides information which is not less valuable than a morphologic analysis of the inferior vena cava, but, in addition, the analysis of the systemic venous return is also useful to estimate right ventricular function as much as in patients with advanced heart failure [10].

Echocardiographic evaluation of right heart performance. Previous studies have described right ventricular enlargement and reduced right ventricular fractional area change as distinctive features in patients with chronic pulmonary hypertension [7,8]. The present study expands those previous observations demonstrating that an in-depth quantitative echocardiographic assessment of right ventricular morphology and function is feasible in such patients using several echo and Doppler parameters. First, the tricuspid annular plane showed a statistically significant correlation with thermodilution-derived right ventricular ejection fraction; future studies should verify its prognostic value in patients with pulmonary hypertension. Second, the pulsed Doppler flow velocity pattern into the superior vena cava turned out to be an indicator of the global right heart performance which is easy to obtain and strongly associated with the hemodynamic profile. Third, the right ventricular free wall thickness could be measured in all patients despite the difficulties in focusing the ultrasonic beam in the near field; it is interesting to notice that the degree of right ventricular hypertrophy was found to be highly variable in the present population. A "severe" RV hypertrophy was associated with a significantly worse right heart hemodynamic profile, and in fact it also indicated poor clinical conditions (worse NYHA class) and poor short-term prognosis.

Conclusion
In patients with chronic pre-capillry pulmonary hypertension, echocardiography not only is useful to estimate pulmonary artery pressures, but it also allows a semi-quantitative assessment of right ventricular geometry and function which is extremely important to evaluate the capability of the right heart to confront with a chronically elevated afterload. Future studies are necessary to estabilish the prognostic significance of these data.

References

1. Boxt LM, Katz FJ, Kolb T. Direct quantitation of right and left ventricular volumes with nuclear magnetic resonance imaging in patients with primary pulmonary hypertension. Am J Physiol 1989; 1508-15.
2. Ritchie M, Waggoner AD, Davila-Roman VG, et al. Echocardiografic characterization of the improvement in right ventricular function in patients with severe pulmonary hypertension after single-lung transplantation. J Am Coll Cardiol 1993; 22:1170-4.
3. Katz WE, Gasior TA, Quinlan JJ, et al. Immediate effects of lung transplantation on right ventricular morphology and function in patients with variable degrees of pulmonary hypertension. J Am Coll Cardiol 1996 Feb; 27(2):384-91.
4. Hoeper MM, Tongers J, Leppert A, Baus S, Maier R, Lotz J. Evaluation of right ventricular performance with a right ventricular ejection fraction thermodilution catheter and MRI in patients with pulmonary hypertension. Chest 2001; 120:502-7.
5. Weir EK, Rubin LJ, Ayres SM et al. The acute administration of vasodilators in primary pulmonary hypertension. Experience from the National Institues of Health Registry on primary pulmonary hypertension. Am Rev Respir Dis 1989; 140:1623-30.
6. D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 1991; 115: 343-9.
7. Hinderliter AL, Willis IV PW, Barst RJ et al. Effects of long term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation 1997; 95:1479-86.
8. Bossone E, Duong-Wagner TH, Paciocco G et al. Echocardiographic features of primary pulmonary hypertension. J Am Soc Echocardiogr 1999; 12:655-62.
9. Ghio S, Recusani F, Klersy C et al. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic cardiomyopathy. Am J Cardiol 2000; 85: 837-42.
10. Ghio S, Recusani F, Sebastiani R et al. Doppler velocimetry in superior vena cava provides useful information on the right circulatory function in patients with congestive heart failure. Echocardiography 2001; 18:469-77.
11. Abraham WT, Raynolds MV, Gottschall B, et al. Importance of angiotensin-coverting enzyme in pulmonary hypertension. Cardiology 1995;86(suppl):9-15.
12. Bristow MR, Zisman LS, Lowes BD, et al The pressure-overloaded right ventricle in pulmonary hypertension. Chest 1998; 114:101S-106S.
13. Auger WR, Fedullo PF, Moser KM et al. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182:393-8.
14. D'Armini AM, Cattadori B, Monterosso C et al. Pulmonary thromboendoarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. EJCTS 2000; 18: 696-702.
15. Rubin LJ. Primary Pulmonary Hypertension. N Engl J Med 1997; 336: 111-7.
16. Ghio S, Raineri C, Scelsi L, Recusani F, D'Armini AM, Piovella F, Klersy C, Campana, C, Viganò M, Tavazzi L. Usefulness and limits of transthoracic echocardiography in the evaluation of patients with primary and chronic thromboembolic pulmonary hypertension. J Am Soc Echo 2002;
17. Baker BJ, Scovil JA, Kane JJ et al. Echocardiographic detection of right ventricular hypertrophy. Am Heart J 1983; 105: 611-4.
18. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapseof the inferior vena cava. Am J Cardiol 1990; 66:493-6.19. Kitabatake A, Inoue M, Asao M et al. Noninvasive evaluation of pulmonary hypertension by a pulsed Doppler technique. Circulation 1983; 68: 302-9.
19. Klein AL, Hatle LK, Burstow DJ et al. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amiloidosis. J Am Coll Cardiol 1990;15:99-108.
20. Gavazzi A, Berzuini C, Campana C, et al. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. J Heart and Lung Transplant 1997;16:774-85.
21. Brecker SJ, Gibbs JS, Fox KM, Yacoub MH, Gibson DG. Comparison of Doppler derived haemodynamic variables and simultaneous high fidelity pressure measurements in severe pulmonary hypertension. Br Heart J 1994;72:384-9.

 

FORM DEACTIVATED SINCE
December 1st., 2003

Your questions, contributions and commentaries will be answered
by the lecturer or experts on the subject in the Pediatric Cardiology list.
Please fill in the form and press the "Send" button.

Question, contribution or commentary:
Name and Surname::
Country::
E-Mail address:

 

 

Top

Updating: 11/28/2003